Saturday, 15 October 2016
October is such a busy month for trainers, their agents and owners, particularly if they are involved in both Flat and National Hunt. The yearling sales have been through their crescendo in the UK with Tattersalls’ Book 1, involving horses with multi-million pound price tags; Champions’ Day at Ascot is on today (and we’re hoping for another superb run from Karl Burke’s brilliant filly, Quiet Reflection) and the first Cheltenham meeting is only a week away. Much to look forward to, as an owner, as long as your horse is fit, well and full of promise.
However, there will be quite a number of horses for whom plans are on hold because they are anything but “fit, well and full of promise”. We all know that even getting a horse to the track in one piece can be a huge challenge, and I often think that in itself often counts as a win. But there is one aspect of owning that gives me a huge amount of concern: where you buy a horse at a sale and then find it has a serious problem that could and should have been disclosed.
Because Owners for Owners has been buying both Flat and NH horses over the Summer and this Autumn, I’ve had my nose well and truly into the sales catalogues of Goffs, Tattersalls, Arqana and Osarus. I am not sure how many people bother ploughing through the voluminous Conditions of Sale, which run to 24 pages in the one that I have in front of me at the moment – Goffs’, and they are a similar length in most other catalogues – but because of my interest in procurement and contracts from my consulting days I am interested in how they are framed and who they are actually protecting. It was always one of my simple views of commercial life that you should be very wary of accepting or signing someone else’s contract because by and large, if they have produced it, it is primarily protecting them and not you. The Conditions of Sale are stated as being of relevance to “all potential vendors and purchasers”, so you would like to think that the contractual terms are balanced and even-handed, protecting both sides equally.
So it came as a huge surprise to see one particular clause in the Goffs catalogue (but also in the Tattersalls one) under the heading of: Lots Returnable, 12.2(e). Basically Section 12 lays out the grounds for returning a horse that you have bought to the sales house, and thence to the vendor. If you buy a horse that is a wind-sucker, weaver, box-walker, wobbler etc., then you can return it. As the buyer you would normally know about these conditions in advance as they are announced by the auctioneer ahead of the horse going through the ring. But Section 12.2(e) deals with wind:
(The lot is returnable if the horse) “has been tubed or otherwise operated on for unsoundness in wind…”
which is absolutely right and proper, as no-one wants to buy a horse whose wind is shot. Unfortunately though there is an important set of qualifiers in parentheses:
“… (Operations to treat the displacement of the soft palate, including the operations tie-forward, cautery of the soft palate, trimming of the soft palate and myectomy are not operations for the correction of an unsoundness in wind within the meaning of this condition.)”
I find this clause absolutely unbelievable, and intend to seek clarification from both the BHA and the ROA on it. In effect it means that if you were a vendor you could operate on the horse to correct what could well be a serious wind problem, then put the horse through the sale where it would be difficult to detect some of these operations, and when the unsuspecting buyer finds out about it, there is absolutely no redress whatsoever.
It may be apocryphal, but apparently there are vets in Ireland who will even perform a minor laser procedure on a horse’s wind box so that it neutralises the sound of bad wind. The operation only succeeds in keeping the horse quiet for a few weeks, but this is enough for the animal to go through the sales.
While preparing this blog I queried this with a well-known vet and he went even further. Apparently you can’t put a horse through the sales if it has bute or Lasix in the system, and that would be detected if there were a blood test. Apparently this doesn’t apply to cortisone, so any vendor can medicate a horse, maybe with serious tendon pain, and even though cortisone could be detected it won’t be declared to the prospective purchaser.
I have a horrible feeling that these are only some of the more public examples of the ways in which the owner is being taken for a ride (if that’s the phrase to use) by the bloodstock industry, sales houses and agents. This is a hugely controversial area, and one that I will come back to again on the blog.